| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 05/29/2013 | EP2597086A1 Cyclic n,n'-diarylthioureas and n,n'-diarylureas as androgen receptor antagonists, anti-cancer agent, method for producing and using same |
| 05/29/2013 | EP2596793A1 Quinoline derivatives as PI3 kinase inhibitors |
| 05/29/2013 | EP2595958A2 Novel processes for the manufacture of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide |
| 05/29/2013 | CN103124731A Fused heteroaryls and their uses |
| 05/29/2013 | CN103124723A Novel microbiocides |
| 05/29/2013 | CN103122000A High-selectivity c-Met kinase inhibitor used as antitumor drug |
| 05/29/2013 | CN103121997A Compound having thiadiazole ring structure substituted with pyridyl group and organic electroluminescent device |
| 05/29/2013 | CN102086198B Method for preparing 1,2-dihydroisoquinoline compounds of pyrazole ring |
| 05/29/2013 | CN101878213B Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes |
| 05/29/2013 | CN101693714B Spirocyclic cyclohexane derivatives |
| 05/29/2013 | CN101622254B Salts of 3-(3-amino-2-(r)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one |
| 05/28/2013 | US8450489 Azaindoles useful as inhibitors of janus kinases |
| 05/28/2013 | US8450343 Gamma secretase modulators |
| 05/28/2013 | US8450342 Perharidines as CDK inhibitors |
| 05/28/2013 | US8450341 Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibitors |
| 05/28/2013 | US8450340 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
| 05/28/2013 | US8450328 Triazolo[4,5-D]pyramidine derivatives and their use as purine receptor antagonists |
| 05/28/2013 | US8450243 Herbicidal quinoline and 1,8-naphthyridine compounds |
| 05/28/2013 | CA2623958C 2-heteroaryl-substituted indole derivative |
| 05/28/2013 | CA2584651C Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds |
| 05/28/2013 | CA2576765C Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors |
| 05/28/2013 | CA2539823C Hemiasterlin derivatives and uses thereof |
| 05/28/2013 | CA2535338C Substituted 1h-imidazo[4,5-c]pyridin-4-amines,1h-imidazo[4,5-c]quinolin -4-amines and 1h-imidazo[4,5-c]naphthyridin-4-amines as immune response modifiers |
| 05/23/2013 | WO2013074986A1 Inhibitors of c-jun-n-terminal kinase (jnk) |
| 05/23/2013 | WO2013073875A1 Novel antiviral pyrrolopyridine derivative and a production method for same |
| 05/23/2013 | WO2013073577A1 Dihydroxy aromatic heterocyclic compound |
| 05/23/2013 | WO2013072882A1 2 -amino- 1, 8 -naphthyridine-3 -carboxamide derivatives as antimicrobial agents |
| 05/23/2013 | WO2013072703A1 Antibacterial drug derivatives |
| 05/23/2013 | WO2013072450A1 Substituted 1,2,5-oxadiazole compounds and their use as herbicides iii |
| 05/23/2013 | WO2013072015A1 Morpholinyl benzotriazine for use in cancer therapy |
| 05/23/2013 | WO2013071880A1 Nitrogen-containing fused ring compounds for use as crth2 antagonists |
| 05/23/2013 | WO2013071698A1 Three-ring pi3k and/or mtor inhibitor |
| 05/23/2013 | WO2013071697A1 Aminoquinazoline derivatives and their salts and methods of use |
| 05/23/2013 | WO2013048214A3 Novel heterocyclic derivatives and their uses |
| 05/23/2013 | US20130131342 Agent exhibiting the properties of a cognitive function promoter (embodiments) |
| 05/23/2013 | US20130131321 LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY |
| 05/23/2013 | US20130131102 Selective glycosidase inhibitors |
| 05/23/2013 | US20130131100 High penetration prodrug compositions of 1h-imidazo[4,5-c]quinolin-4-amines and 1h-imidazo[4,5-c]quinolin-4-amine-related compounds and uses thereof |
| 05/23/2013 | US20130131099 Compounds and methods of treating brain disorders |
| 05/23/2013 | US20130131084 Use of derivatives of indoles for the treatment of cancer |
| 05/23/2013 | US20130131077 Pyrido[3,4-b]indoles and methods of use |
| 05/23/2013 | US20130131070 1-Aryl or 1- Heteroaryl-Pyrido(B)indoles and Uses Thereof |
| 05/23/2013 | US20130131062 Pyridazinones and furan-containing compounds |
| 05/23/2013 | US20130131060 3-(indolyl)- or 3-(azaindolyl)- 4-arylmaleimide compounds and their use in tumor treatment |
| 05/23/2013 | US20130131058 2-substituted-8-alkyl-7-oxo-7,8-dihydropyrido[2,3-d] pyrimidine-6-carbonitriles and uses thereof |
| 05/23/2013 | US20130131050 Fused heterocyclic compound and application thereof |
| 05/23/2013 | US20130131041 Spirocyclic compounds |
| 05/23/2013 | US20130131038 N-containing heteroaryl derivatives as jak3 kinase inhibitors |
| 05/23/2013 | US20130131035 Carboxamides as inhibitors of voltage-gated sodium channels |
| 05/23/2013 | US20130129812 Novel compositions and methods for treating cancer |
| 05/23/2013 | DE102011119127A1 3-Cyanaryl-1H-pyrrolo[2.3-b]pyridin-Derivate 3-Cyanaryl-1H-pyrrolo [2.3-b] pyridine derivatives |
| 05/23/2013 | CA2856291A1 Inhibitors of c-jun-n-terminal kinase (jnk) |
| 05/23/2013 | CA2856103A1 Morpholinyl benzotriazine for use in cancer therapy |
| 05/23/2013 | CA2856100A1 Nitrogen-containing fused ring compounds as crth2 antagonists |
| 05/23/2013 | CA2854100A1 Substituted 1,2,5-oxadiazole compounds and their use as herbicides iii |
| 05/23/2013 | CA2851151A1 Aminoquinazoline derivatives and their salts and methods of use |
| 05/22/2013 | EP2594568A1 Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes |
| 05/22/2013 | EP2594567A1 Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof |
| 05/22/2013 | EP2593460A1 7, 9-nitrogen radical-4-oxo-4h-pyrido[l,2-a]pyrimidine-2-carboxylic acid benzylamide anti-virals |
| 05/22/2013 | EP2593454A1 New azacyclic compounds |
| 05/22/2013 | EP2593453A1 Azaindazole compounds |
| 05/22/2013 | EP2593452A1 Ip receptor agonist heterocyclic compounds |
| 05/22/2013 | EP2593451A2 Substituted imidazo[1,2-a]pyrimidines and -pyridines |
| 05/22/2013 | EP2593450A1 Substituted imidazoquinoline derivatives as kinase inhibitors |
| 05/22/2013 | CN103119044A Calcium salt of pyrroloquinoline quinone |
| 05/22/2013 | CN103119043A Fused heterocyclic compound and application thereof |
| 05/22/2013 | CN103119042A Novel heterocyclic compound, and composition for treating inflammatory diseases using same |
| 05/22/2013 | CN103119041A Paxillin stimulating compositions and cosmetic uses thereof |
| 05/22/2013 | CN103119035A Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors |
| 05/22/2013 | CN103118679A Novel conjugates of CC-1065 analogs and bifunctional linkers |
| 05/22/2013 | CN103113370A Method for purifying baptifoline from radix sophorae flavescentis |
| 05/22/2013 | CN103113369A Benzo [b][1,8]-naphthyridine-2-(1H)-imide derivative with antitumor activity and synthetic method thereof |
| 05/22/2013 | CN103113368A Hexahydro-phenanthro tetrahydroindolizine compounds, and preparation method and application thereof |
| 05/22/2013 | CN103113367A Preparation method of full-aromaticity beta-carboline compound |
| 05/22/2013 | CN103113291A Synthesis method of 3-position alkenyl pyridine derivatives |
| 05/22/2013 | CN103113289A Organic electroluminescent material containing benzanthracene derivative and preparation method of organic electroluminescent material |
| 05/22/2013 | CN103113281A Benzanthracene efficient organic light emitting material and preparation method |
| 05/22/2013 | CN103110966A Fluoride-18 marked dopamine D4 receptor developing agent and preparation method thereof |
| 05/22/2013 | CN102036959B Polysubstituted 2-aryl-6-phenyl-imidazo[l,2-a] pyridine derivatives, and preparation and therapeutic use thereof |
| 05/22/2013 | CN102026998B Spirocyclic derivatives as histone deacetylase inhibitors |
| 05/22/2013 | CN101932580B Imidazopyridine kinase inhibitors |
| 05/22/2013 | CN101365446B Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| 05/22/2013 | CN101316823B 2,4,5-triphenyl imidazoline derivatives as inhibitors of interaction between p53 and MDM2 proteins for use as anticancer agents |
| 05/21/2013 | US8445700 Process for the preparation of optically active N-benzyl-3 hydroxypyrrolidines |
| 05/21/2013 | US8445681 Azaindazoles useful as inhibitors of kinases |
| 05/21/2013 | US8445528 Dendrimer conjugates |
| 05/21/2013 | US8445525 Carboxylic acid amides, the preparation thereof and their use as medicaments |
| 05/21/2013 | US8445510 Fused bicyclic kinase inhibitors |
| 05/21/2013 | US8445477 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 05/21/2013 | CA2580446C Method for enantioselective preparation of sulphoxide derivatives |
| 05/21/2013 | CA2560454C Azaindoles useful as inhibitors of jak and other protein kinases |
| 05/21/2013 | CA2560162C Inhibitors of iap |
| 05/16/2013 | WO2013070911A1 Compounds and methods for treating cystic fibrosis |
| 05/16/2013 | WO2013070659A1 Modulators of opioid receptors and methods of use thereof |
| 05/16/2013 | WO2013070117A2 Fluorine-containing substituted 5-[2-(pyrid-3-yl)-ethyl]-2,3,4-tetrahydro-1н-pyrido[4,3-b]indoles and hydrochlorides and hydrobromides thereof as agents for reducing uncontrolled protein aggregation in the nervous system, pharmacological agent based thereon and method for using same |
| 05/16/2013 | WO2013069762A1 Cyclic azine compound having nitrogen-containing fused aromatic group, method for producing same, and organic electroluminescent element using same as constituent component |
| 05/16/2013 | WO2013069721A1 Metal complex, and adsorbent, absorbent and separator formed of same |
| 05/16/2013 | WO2013068972A1 Nadph oxidase 4 inhibitors and use thereof |
| 05/16/2013 | WO2013068875A1 2-thiopyrimidinones |
| 05/16/2013 | WO2013068769A1 Pharmaceutical compounds |